BiotechTube
Home/Anavex Life Sciences/Terrie Kellmeyer, PhD
TK

Terrie Kellmeyer, PhD

Senior Vice President of Clinical Development

Anavex Life Sciences

Therapeutic Areas

Neurodegenerative DiseasesNeurodevelopmental Disorders

Anavex Life Sciences Pipeline

DrugIndicationPhase
Blarcamesine (ANAVEX®2-73)Alzheimer’s DiseasePhase 2b/3
ANAVEX®3-71SchizophreniaPhase 2
ANAVEX®1-41CNS DisordersPreclinical
ANAVEX®1066Not SpecifiedDiscovery/Preclinical

Leadership Team at Anavex Life Sciences

CU
Christopher U. Missling, PhD, MS, MBA
President and Chief Executive Officer
JC
Juan Carlos Lopez-Talavera, MD, PhD
Senior Vice President, Head of Research and Development
WL
Wolfgang Liedtke, MD, PhD
Senior Vice President, Global Head of Neurology
KJ
Kun Jin, PhD
Vice President and Head of Biostatistics
DK
Daniel Klamer, PhD, MS, MBA
Vice President of Business Development and Scientific Strategy
DA
Dr. Adebayo Laniyonu, PhD
Senior Vice President for Nonclinical Development
DM
Dr. Marwan N Sabbagh, MD
Scientific Advisor
View full Anavex Life Sciences profile